Britains GSK to buy Affinivax for up to $3.3 bln in vaccines push

Britains GSK to buy Affinivax for up to $3.3 bln in vaccines push

By, Admin 1 June 2022

GSK, the world's largest vaccine maker by sales, has been under pressure to shore up its pipeline. Last month, it indicated an appetite for further deals after spending $1.9 billion to buy Sierra Oncology to bolster its cancer business. GSK pay up to $3.3 billion to acquire privately held biopharmaceutical firm Affinivax to bolster its vaccine pipeline, a key area of focus as the British drugmaker prepares to separate its consumer unit. GSK, the world's largest vaccine maker by sales, has been under pressure to shore up its pipeline. Last month, it indicated an appetite for further deals after spending $1.9 billion to buy Sierra Oncology to bolster its cancer business. U.S.-based Affinivax is developing next-generation vaccines, the company said, the most advanced of which are for pneumococcal diseases, including pneumonia, meningitis and sinusitis. GSK will pay Affinivax $2.1 billion upfront and up to $1.2 billion in potential development milestones. The London-listed company on Tuesday also reiterated its outlook for 2022 and its medium-term targets.

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!